Documente Academic
Documente Profesional
Documente Cultură
Medicatie ICC Cu FE Scazuta
Medicatie ICC Cu FE Scazuta
Toti pacientii
Antialderosteronic
Simptome persistente
(clasa NYHA II-IV). IECA/ SARTAN + B-BLOCANT
+ +
FE ≤ 35% deja in terapie cu ANTIALDOSTERONIC
IECA/ SARTAN + B-BLOCANT
Sartan
1.FE ≤ 40% si
Nu tolereaza IECA SARTAN + B-BLOCANT
2. Simptome persistente
(clasa NYHA II-IV) IECA + B-BLOCANT
+ +
FE ≤ 40% deja in terapie cu SARTAN
IECA + B-BLOCANT
Si
NU tolereaza antialdosteronicele
Digoxin
1.Simptome persistente
(clasa NYHA II-IV) IECA/ SARTAN + B-BLOCANT
+ +
FE ≤ 45% deja in terapie cu ANTIALDOSTERONIC
IECA/ SARTAN + B-BLOCANT +
+ DIGOXIN
ANTIALDOSTERONIC
2. FE ≤ 45% + VS dilatat
sau B-BLOCANT + ANTIALDOSTERONIC
FE ≤35% +
Hidralazina-izosorbid d. HIDRALAZINA-IZOSORBID D.
Poate fi utilizata ca si o
Alternativa la IECA si Sartani
La pacientii tratati optim cu
B-BLOCANT + ANTIALDOSTERONIC
Ivabradina
1.Simptome persistente
(Clasa NYHA II-IV)
+
In ritm sinusal IECA/ SARTAN + B-BLOCANT
+ +
FE ≤35% ANTIALDOSTERONIC
+ +
Frecventa cadiaca >70 bpm IVABRADINA
Deja in derapie cu doza maxima
IECA/ SARTAN + B-BLOCANT
+
ANTIALDOSTERONIC
2. 1.Simptome persistente
(Clasa NYHA II-IV)
+
In ritm sinusal IECA/ SARTAN + IVABRADINA
+ +
FE ≤35% ANTIALDOSTERONIC
+ +
Frecventa cadiaca >70 bpm
si
NU tolereaza beta blocantul
Sau il locul beta blocantului
Pacientii trebuie sa primeasa
IECA/Sartam +antialderosteronic